[62] Because of the hepatic metabolism of repaglinide, the manufacturer recommends that a repaglinide-metformin combination tablet should be avoided in patients with hepatic impairment. On a ...

Expert Rev Endocrinol Metab. 2010;5(3):331-342. Metformin also forms the cornerstone of dual therapy and is used extensively in combination with several classes of OADs. The safety and efficacy of ...